Limflow Receives FDA Approval for U.S. Pivotal Study of Minimally-Invasive Technology Designed to Prevent Amputations in Chronic Limb-Threatening Ischemia Patients

By Natalie GoodridgeSeptember 19, 2019October 24th, 2024Healthcare

Limflow Receives FDA Approval for U.S. Pivotal Study of Minimally-Invasive Technology Designed to Prevent Amputations in Chronic Limb-Threatening Ischemia Patients

https://limflow.com/limflow-receives-fda-approval-for-u-s-pivotal-study-of-minimally-invasive-technology-designed-to-prevent-amputations-in-chronic-limb-threatening-ischemia-patients/

Limflow Receives FDA Approval for U.S. Pivotal Study of Minimally-Invasive Technology Designed to Prevent Amputations in Chronic Limb-Threatening Ischemia Patients

Limflow Receives FDA Approval for U.S. Pivotal Study of Minimally-Invasive Technology Designed to Prevent Amputations in Chronic Limb-Threatening Ischemia Patients

Tags:

PreviousCagent Vascular Appoints Medical Device Industry Veteran Brian Walsh as Chairman of the Board

NextCorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact